{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "32003160", "DateCompleted": {"Year": "2020", "Month": "02", "Day": "10"}, "DateRevised": {"Year": "2020", "Month": "02", "Day": "13"}, "Article": {"Language": ["rus"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "1728-2985", "JournalIssue": {"Issue": "6", "PubDate": {"Year": "2019", "Month": "Dec", "Day": "31"}}, "Title": "Urologiia (Moscow, Russia : 1999)", "ISOAbbreviation": "Urologiia"}, "ArticleTitle": "[Transrectal ozone and magnetic therapy for treatment of chronic bacterial prostatitis].", "Pagination": {"StartPage": "6", "EndPage": "11", "MedlinePgn": "6-11"}, "Abstract": {"AbstractText": ["To evaluate the efficiency of combined transrectal ozone and magnetic therapy for the treatment of chronic bacterial prostatitis (CBP).", "A total of 142 men with CBP were included in the study and allocated to different treatment, including standard therapy for 6 weeks (n=40), transrectal magnetic therapy in addition to standard therapy (n=35), transrectal ozone therapy in addition to standard therapy (n=37), transrectal magnetic and ozone therapy in addition to standard therapy (n=30). Treatment results were evaluated 3 months after the completion of therapy.", "The most pronounced positive improvement in all evaluated parameters was observed among patients who received both magnetic and ozone therapy, according to the criteria of all domains of the NIH-CPSI questionnaire, IIEF-5 questionnaire, and based on the changes in prostate volume, maximum urination rate, residual urine volume and microscopic examination of prostate secretion.", "To achieve optimal results in the treatment of CBP, it is necessary to use both consequently magnetic and ozone therapy, in addition to standard therapy."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "GBU of Republic Dagestan City clinical hospital 1, Makhachkala, Russia."}], "LastName": "Katibov", "ForeName": "M I", "Initials": "MI"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "GBU of Republic Dagestan City clinical hospital 1, Makhachkala, Russia."}], "LastName": "Alibekov", "ForeName": "M M", "Initials": "MM"}], "PublicationTypeList": ["Clinical Trial", "Journal Article"]}, "MedlineJournalInfo": {"Country": "Russia (Federation)", "MedlineTA": "Urologiia", "NlmUniqueID": "100900900", "ISSNLinking": "1728-2985"}, "ChemicalList": [{"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Chronic Disease"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Magnetic Phenomena"}, {"QualifierName": [], "DescriptorName": "Magnetics"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Ozone"}, {"QualifierName": ["therapy"], "DescriptorName": "Prostatitis"}, {"QualifierName": [], "DescriptorName": "Surveys and Questionnaires"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2020", "Month": "2", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "2", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "2", "Day": "11", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32003160"]}}], "PubmedBookArticle": []}